Reduction of risk factors for cardiovascular diseases in African Americans with a 12-week nutrition education program

Nutrition Research

Volumn 27, Issue 5, 2007, Pages 252-257

  Qian, Jing ^a   Wang, Baowu ^a   Dawkins, Norma ^a   Gray, Alexandria ^a   Pace, Ralphenia D ^a  

^a TUSKEGEE UNIVERSITY   (United States)

Author keywords

African Americans; C reactive protein; Cardiovascular disease; Glutathione peroxidase; High density lipoprotein cholesterol; Low density lipoprotein cholesterol; Nutrition education

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SCAVENGER; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGED; ANTHROPOMETRY; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; EDUCATION PROGRAM; ENZYME ACTIVITY; FEMALE; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MALE; NUTRITION EDUCATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; STUDENT T TEST; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 34249084930     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2007.03.005     Document Type: Article

References (40)

1. American Heart Association. Heart disease and stroke statistics-2005 update (2005), American Heart Association, Dallas (Tex)
2. National Cholesterol Education Program (NCEP). The expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
3. Ridker P.M. Evaluating novel cardiovascular risk factors. Ann Intern Med 130 (1999) 933-937
4. Mass R., and Boger R.H. Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atheroscler Suppl 4 (2003) 5-17
5. Gates G., and McDonald M. Comparison of dietary risk factors for cardiovascular disease in African-American and white women. J Am Diet Assoc 97 (1997) 1394-1400
6. Clark L.T. Primary prevention of cardiovascular disease in high-risk patients: physiologic and demographic risk factor differences between African American and white American populations. Am J Med 107 (1999) 22S-24S
7. James S.A. Primordial prevention of cardiovascular disease among African Americans: a social epidemiological perspective. Prev Med 29 (1999) S84-S89
8. Kuller L.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 144 (1996) 537-547
9. Koenig W., Sund M., Frohlich M., Fischer H., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
10. Mendall M.A., Strachan D.P., Butland B.K., Ballam L., Morris J., Sweetnam P.M., et al. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men. Eur Heart J 21 (2000) 1584-1590
11. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
12. Burke A.P., Tracy R.P., Kolodgie F., Malcom G.T., Zieske A., Kutys R., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death. Circulation 105 (2002) 2019-2023
13. Grundy S.M., Balady G.J., Criqui M.H., Fletcher G., Greenland P., Hiratzka L.F., et al. Primary prevention of coronary heart disease: guidance from Framingham. A statement for healthcare professionals from the AHA task force on risk reduction. Circulation 97 (1998) 1876-1887
14. Steinbrecher U.P., Zhang H., and Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic Biol Med 9 (1990) 155-168
15. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet 344 (1994) 793-795
16. Fang Y., Yang S., and Wu G. Free radicals, antioxidants, and nutrition. Nutrition 18 (2002) 872-879
17. Mensah G.A. Eliminating disparities in cardiovascular health. Circulation 111 (2005) 1332-1336
18. Lohman T.G., Roche A.F., and Martorel R. Anthropometric standardization reference manual (1988), Human Kinetics, Champaign (Ill)
19. Bechman Coulter, Inc. Synchron System(s) Chemistry Information Sheet. Cholesterol kit recorder number 467825; HDL cholesterol kit recorder number 467820 (2003), Beckman Coulter, Inc., Fullerton (Calif)
20. Samman S., and Truswell A.S. The Friedewald equation for the determination of low-density-lipoprotein cholesterol: a special case. Am J Clin Nutr 58 (1993) 928-929
21. Anogen Inc. Human CRP ELISA kit, cat no. EL10022 (2005), Mississauga, Ontario (Canada)
22. Cayman Chemical Company. Glutathione peroxidase kit, cat. no. 703102 (2005) [Ann Arbor, MI]
23. Molyneux P. The use of the stable free radical diphenylpicrylhydrazyl (DPPH) for estimating antioxidant activity. Songklanakarin J Sci Technol 26 (2004) 211-219
24. SPSS Inc. SPSS Base 13.0 user's guide, chapter 21, t tests (2005), SSPS Inc., Chicago (Ill)
25. Pearson T.A., Blair S.N., Daniels S.R., Eckel R.H., Fair J.M., Fortmann S.P., et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 106 (2002) 388-391
26. In: Insel P., Turner R.E., and Ross D. (Eds). Discovering nutrition. 2nd ed. (2006), Jones and Bartlett Publishers, Sudbury (Mass) 271-315
27. Law M.R., Wald N.J., and Thompson S.G. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischemic heart disease?. Br Med J 308 (1994) 367-372
28. Gotto A.M., and Pownall H.J. Manual of lipid disorders: reducing the risk for coronary heart disease. 2nd ed. (1992), Williams & Wilkins, Baltimore (Md)
29. Saito M., Ishimitsu T., Minami J., Ono H., Ohrui M., and Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 167 (2003) 73-79
30. Visser M., Bouter L.M., McQuillan G.M., Wener M.H., and Harris T.B. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (1999) 2131-2135
31. King D.E., Egan B.M., and Geesey M.E. Relation of dietary fat and fiber to elevation of C-reactive protein. Am J Cardiol 92 (2003) 1335-1339
32. Church T.S., Earnest C.P., Wood K.A., and Kampert J.B. Reduction of C-reactive protein levels through use of a multivitamin. Am J Med 115 (2003) 702-707
33. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 (1997) 973-979
34. Ridker P.M., Rifai N., Clearfield M., Downs J.R., Weis S.E., Miles S.J., et al. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344 (2001) 1959-1965
35. Ikonomidis I., Andreotti F., and Economou E. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100 (1999) 793-798
36. Blois M.S. Antioxidant determinations by the use of a stable free radical. Nature 4617 (1958) 1199-1200
37. Sies H. Oxidative stress: oxidants and antioxidants (1991), Academic Press, London, San Diego, CA
38. Dragsted L.O., Pedersen A., Hermetter A., Basu S., Hansen M., and Haren G.R. The 6-a-day study: effects of fruits and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers. Am J Clin Nutr 79 (2004) 1060-1072
39. Elosua R., Molina L., Fito M., Arquer A., Sanchez-Quesada J.L., Covas M.I., et al. Response of oxidative stress biomarkers to a 16-week aerobic physical activity program, and to acute physical activity, in healthy young men and women. Atherosclerosis 167 (2003) 327-334
40. Venardos K., Harrison G., Headrick J., and Perkins A. Effects of dietary selenium on glutathione peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J Trace Elem Med Biol 18 (2004) 81-88